GENE ONLINE|News &
Opinion
Blog

China
Coherent Biopharma, WuXi STA Collab Takes a Crack at Peptide-Drug Conjugates
2021-12-06
BeiGene launches IPO on Shanghai’s STAR market to raise $3B
2021-12-03
Ablaze Pharma Launches with $75 Million to Bring Targeted Radiotherapies into China
2021-12-01
After Raising $300 Million, China’s Abogen Hunkers Down on mRNA Covid-19 Vaccine with GenScript and Walvax
2021-12-01
China’s Neurophth Snags $63 Million in Series C to Boost Ophthalmic Gene Therapy Portfolio
2021-11-25
I-Mab Inks $315 Million Pact with Jumpcan to Market Human Growth Hormone in China
2021-11-11
Zai Lab Buys Rights to Three Assets, Including Its First Neuroscience Drug
2021-11-10
Chinese Vaccine Maker Raises $240 Million in Hong Kong Debut
2021-11-08
WuXi Biologics Launch Its Largest GMP Drug Facility and First Automated Vial Packaging Line
2021-11-03
Shanghai Startup Lands $325 Million Nasdaq IPO to Advance Phase 3 Assets
2021-11-02
Angel Pharma Pushes First-In-Class ITK Inhibitor into Trial in China
2021-10-27
Shanghai Startup Poised for $325M IPO on Nasdaq
2021-10-21
Diabetes Care Device Maker Debuts On Hong Kong Exchange
2021-10-20
WuXi ATU Launches Fourth Manufacturing Site for Gene and Cell Therapy CTDMO Service
2021-10-19
Is the Race On for RNAi? A Chinese Pharma’s $450M Deal May Just Be the Start
2021-10-13
1 2 3 4
LATEST
Novel RAGE Antagonist Stirs Hopes for Countering Diabetic Complications
2021-12-07
AstraZeneca Blocks Private Equity Buyout of Swedish Pharma Sobi
2021-12-06
How CDMOs are Restructuring the Biopharma Landscape – An Interview with Bobby Sheng
2021-12-06
BeiGene launches IPO on Shanghai’s STAR market to raise $3B
2021-12-03
Novartis, UCB Take Aim at Parkinson’s Disease Under $1.65 Billion Collab
2021-12-03
Atara Biotherapeutics’ First-In-Class Allogeneic T-Cell Therapy Accepted for EMA Review
2021-12-02
Astellas Taps Dyno in $1.6+ Billion Deal to Develop AAV Gene Therapies
2021-12-02
EVENT
2021-12-13
63rd ASH ANNUAL MEETING AND EXPOSITION
Georgia, USA
2021-12-28
BIOHK2021
Hong Kong, China
Scroll to Top

Create an account with us now to say goodbye to all the pop-ups!